Inovio Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application of its DNA vaccine candidate INO-4800 against Covid-19.
Inovio Pharmaceuticals has received a $5m grant from the Bill & Melinda Gates Foundation to support the testing and scale-up of a smart delivery device for Covid-19 vaccine, INO-4800.
Inovio Pharmaceuticals has expedited its timeline for the development of a Covid-19 vaccine candidate, INO-4800, with human clinical trials scheduled for April.